Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:3633-3643
doi: 10.1161/CIRCULATIONAHA.105.555623
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yano, M.
Right arrow Articles by Matsuzaki, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yano, M.
Right arrow Articles by Matsuzaki, M.
Related Collections
Right arrow Congestive
Right arrow Animal models of human disease

(Circulation. 2005;112:3633-3643.)
© 2005 American Heart Association, Inc.


Heart Failure

Correction of Defective Interdomain Interaction Within Ryanodine Receptor by Antioxidant Is a New Therapeutic Strategy Against Heart Failure

Masafumi Yano, MD, PhD; Shinichi Okuda, MD, PhD; Tetsuro Oda, MD; Takahiro Tokuhisa, MD; Hiroki Tateishi, MD; Mamoru Mochizuki, MD; Toshiyuki Noma, BS; Masahiro Doi, MD, PhD; Shigeki Kobayashi, MD, PhD; Takeshi Yamamoto, MD, PhD; Yasuhiro Ikeda, MD, PhD; Tomoko Ohkusa, MD, PhD; Noriaki Ikemoto, PhD; Masunori Matsuzaki, MD, PhD

From the Department of Medical Bioregulation, Division of Cardiovascular Medicine, Yamaguchi University School of Medicine, Yamaguchi, Japan (M.Y., S.O., T. Oda, T.T., H.T., M. Mochizuki, T.N., M.D., S.K., T.Y., Y.I., T. Ohkusa, M. Matsuzaki); Boston Biomedical Research Institute, Watertown, Mass (N.I.); and Department of Neurology, Harvard Medical School, Boston, Mass (N.I.).

Correspondence to Masafumi Yano, MD, PhD, Department of Medical Bioregulation, Division of Cardiovascular Medicine, Yamaguchi University School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan. E-mail yanoma{at}yamaguchi-u.ac.jp

Received April 13, 2005; revision received September 13, 2005; accepted September 19, 2005.

Background— Defective interdomain interaction within the ryanodine receptor (RyR2) seems to play a key role in the pathogenesis of heart failure, as shown in recent studies. In the present study we investigated the effect of oxidative stress on the interdomain interaction, its outcome in the cardiac function in heart failure, and the possibility of preventing the problem with antioxidants.

Methods and Results— Sarcoplasmic reticulum (SR) vesicles were isolated from dog left ventricular (LV) muscle (normal or rapid ventricular pacing for 4 weeks with or without the antioxidant edaravone). In the edaravone-treated paced dogs (EV+), but not in the untreated paced dogs (EV–), normal cardiac function was restored almost completely. In the SR vesicles isolated from the EV–, oxidative stress of the RyR2 (reduction in the number of free thiols) was severe, but it was negligible in EV+. The oxidative stress of the RyR2 destabilized interdomain interactions within the RyR2 (EV–), but its effect was reversed in EV+. Abnormal Ca2+ leak through the RyR2 was found in EV– but not in EV+. The amount of the RyR2-bound FKBP12.6 was less in EV– than in normal dogs, whereas it was restored almost to a normal amount in EV+. The NO donor 3-morpholinosydnonimine (SIN-1) reproduced, in normal SR, several abnormal features seen in failing SR, such as defective interdomain interaction and abnormal Ca2+ leak. Both cell shortening and Ca2+ transients were impaired by SIN-1 in isolated normal myocytes, mimicking the pathophysiological conditions in failing myocytes. Incubation of failing myocytes with edaravone restored the normal properties.

Conclusions— During the development of heart failure, edaravone ameliorated the defective interdomain interaction of the RyR2. This prevented Ca2+ leak and LV remodeling, leading to an improvement of cardiac function and an attenuation of LV remodeling.


Key Words: calcium • free radicals • heart failure • sarcoplasmic reticulum




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
C. Jung, A. S. Martins, E. Niggli, and N. Shirokova
Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways
Cardiovasc Res, March 1, 2008; 77(4): 766 - 773.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Yamamoto, M. Yano, X. Xu, H. Uchinoumi, H. Tateishi, M. Mochizuki, T. Oda, S. Kobayashi, N. Ikemoto, and M. Matsuzaki
Identification of Target Domains of the Cardiac Ryanodine Receptor to Correct Channel Disorder in Failing Hearts
Circulation, February 12, 2008; 117(6): 762 - 772.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. H. George
Sarcoplasmic reticulum Ca2+ leak in heart failure: mere observation or functional relevance?
Cardiovasc Res, January 15, 2008; 77(2): 302 - 314.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Yan, J. Liu, C. Wei, K. Li, W. Xie, Y. Wang, and H. Cheng
Bidirectional regulation of Ca2+ sparks by mitochondria-derived reactive oxygen species in cardiac myocytes
Cardiovasc Res, January 15, 2008; 77(2): 432 - 441.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. R. Gonzalez, F. Beigi, A. V. Treuer, and J. M. Hare
Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes
PNAS, December 18, 2007; 104(51): 20612 - 20617.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
T. Seidler, G. Hasenfuss, and L. S. Maier
Targeting Altered Calcium Physiology in the Heart: Translational Approaches to Excitation, Contraction, and Transcription
Physiology, October 1, 2007; 22(5): 328 - 334.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Mochizuki, M. Yano, T. Oda, H. Tateishi, S. Kobayashi, T. Yamamoto, Y. Ikeda, T. Ohkusa, N. Ikemoto, and M. Matsuzaki
Scavenging Free Radicals by Low-Dose Carvedilol Prevents Redox-Dependent Ca2+ Leak Via Stabilization of Ryanodine Receptor in Heart Failure
J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1722 - 1732.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. E. D. J. ter Keurs and P. A. Boyden
Calcium and Arrhythmogenesis
Physiol Rev, April 1, 2007; 87(2): 457 - 506.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. E. Murdoch, M. Zhang, A. C. Cave, and A. M. Shah
NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure
Cardiovasc Res, July 15, 2006; 71(2): 208 - 215.
[Abstract] [Full Text] [PDF]